+22.7%
NU vs EMR
+92.2%
-69.5%
-72.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.1% | -3.4% | -0.6% | -2.0% |
| 7D | +2.6% | -4.9% | +7.5% | +5.9% |
| 30D | -12.9% | -0.2% | -12.8% | -12.9% |
| 3M | -16.7% | -1.2% | -15.6% | -16.3% |
| 6M | +4.0% | +21.6% | -17.6% | -8.8% |
| YTD | -24.3% | +22.9% | -47.1% | -35.3% |
| 1Y | -19.8% | +27.8% | -47.6% | -33.4% |
| 3Y | +61.5% | +93.1% | -31.6% | -5.7% |
| All | +22.7% | +92.2% | -69.5% | -28.2% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling